2010-11473. National Cancer Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Adult Brain Tumor Consortium.

    Date: May 20, 2010.

    Time: 1 p.m. to 2 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institutes of Health, 6116 Executive Boulevard, Room 6006, Rockville, MD 20852 (Telephone Conference Call).

    Contact Person: Gerald G. Lovinger, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892-8329, 301/496-7987, lovingeg@mail.nih.gov.

    This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Small Grants Program for Cancer Epidemiology.

    Date: June 17-18, 2010.

    Time: 8:30 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.

    Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286, peguesj@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Technology Development.

    Date: June 23-24, 2010.

    Time: 8 a.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904, decluej@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Comprehensive Minority Institution Cancer Center Partnership.

    Date: June 29-30, 2010.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.

    Contact Person: Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892, 301-496-7575, palekarl@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Nanotechnology Imaging and Sensing Platforms.

    Date: June 29, 2010.

    Time: 11 a.m. to 5 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institutes of Health, 6116 Executive Boulevard, Conference Room 707, Rockville, MD 20852 (Telephone Conference Call).Start Printed Page 26969

    Contact Person: Caron A. Lyman, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8119, Bethesda, MD 20892-8328, 301-451-4761, lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Bridge to Cancer Therapeutics.

    Date: June 30-July 1, 2010.

    Time: 8 a.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.

    Contact Person: Savvas C. Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH 6116 Executive Blvd., Rm 8053, Bethesda, MD 20892, 301-496-7421, makridessc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; Transdisciplinary Research in Energetics and Cancer.

    Date: July 6-7, 2010.

    Time: 8 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Westin at Old Town Alexandria, 400 Courthouse Square, Alexandria, VA 22314.

    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, msalin@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; AIDS Malignancy Clinical Trials Consortium.

    Date: July 8-9, 2010.

    Time: 8:30 a.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.

    Contact Person: Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286, peguesj@mail.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: May 7, 2010.

    Jennifer Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2010-11473 Filed 5-12-10; 8:45 am]

    BILLING CODE 4140-01-P